Carrier detection for Sjögren-Larsson syndrome

T. L. Kelson, D. A. Craft, W. B. Rizzo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder associated with reduced activity of the fatty alcohol: NAD+ oxidoreductase complex (FAO). Recent studies indicate that SLS patients are specifically deficient in the fatty aldehyde dehydrogenase (FALDH) component of FAO. To investigate the possibility of carrier detection for SLS, FAO and FALDH activities were measured in cultured skin fibroblasts from normal controls, obligate SLS heterozygotes, and SLS homozygotes using the 18-carbon substrates octadecanol and octadecanal. Three of 11 heterozygotes for SLS had FAO activities that were within the normal range; the other 8 SLS heterozygotes had FAO activities below normal. In contrast, fibroblast FALDH activity was more effective than FAO in discriminating SLS heterozygotes from normal controls. FALDH activity (nmol min-1 (mg protein)-1) in normal controls was 8.54 ± 1.16 (mean ± SD; range 6.95-10.77;n=12) and in SLS heterozygotes was 5.12 ± 1.31 (range 3.28-6.96;n=11), or 60 ± 15% of mean normal activity. One SLS heterozygote had an FALDH activity within the lower range of normal; this heterozygote had an FAO activity below normal. None of the SLS heterozygotes had an FAO or FALDH activity that was in the range of that measured in SLS homozygotes. These results indicate that measurement of FAO and FALDH activities in cultured skin fibroblasts using 18-carbon substrates is useful for SLS carrier detection.

Original languageEnglish (US)
Pages (from-to)105-111
Number of pages7
JournalJournal of Inherited Metabolic Disease
Volume15
Issue number1
DOIs
StatePublished - Jan 1 1992

Fingerprint

long-chain-aldehyde dehydrogenase
Heterozygote
long-chain-alcohol dehydrogenase
Fibroblasts
Homozygote
Reference Values
Carbon
Skin

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Carrier detection for Sjögren-Larsson syndrome. / Kelson, T. L.; Craft, D. A.; Rizzo, W. B.

In: Journal of Inherited Metabolic Disease, Vol. 15, No. 1, 01.01.1992, p. 105-111.

Research output: Contribution to journalArticle

Kelson, T. L. ; Craft, D. A. ; Rizzo, W. B. / Carrier detection for Sjögren-Larsson syndrome. In: Journal of Inherited Metabolic Disease. 1992 ; Vol. 15, No. 1. pp. 105-111.
@article{9172d43c93fa4fcf998f7910b377a0ec,
title = "Carrier detection for Sj{\"o}gren-Larsson syndrome",
abstract = "Sj{\"o}gren-Larsson syndrome (SLS) is an autosomal recessive disorder associated with reduced activity of the fatty alcohol: NAD+ oxidoreductase complex (FAO). Recent studies indicate that SLS patients are specifically deficient in the fatty aldehyde dehydrogenase (FALDH) component of FAO. To investigate the possibility of carrier detection for SLS, FAO and FALDH activities were measured in cultured skin fibroblasts from normal controls, obligate SLS heterozygotes, and SLS homozygotes using the 18-carbon substrates octadecanol and octadecanal. Three of 11 heterozygotes for SLS had FAO activities that were within the normal range; the other 8 SLS heterozygotes had FAO activities below normal. In contrast, fibroblast FALDH activity was more effective than FAO in discriminating SLS heterozygotes from normal controls. FALDH activity (nmol min-1 (mg protein)-1) in normal controls was 8.54 ± 1.16 (mean ± SD; range 6.95-10.77;n=12) and in SLS heterozygotes was 5.12 ± 1.31 (range 3.28-6.96;n=11), or 60 ± 15{\%} of mean normal activity. One SLS heterozygote had an FALDH activity within the lower range of normal; this heterozygote had an FAO activity below normal. None of the SLS heterozygotes had an FAO or FALDH activity that was in the range of that measured in SLS homozygotes. These results indicate that measurement of FAO and FALDH activities in cultured skin fibroblasts using 18-carbon substrates is useful for SLS carrier detection.",
author = "Kelson, {T. L.} and Craft, {D. A.} and Rizzo, {W. B.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1007/BF01800352",
language = "English (US)",
volume = "15",
pages = "105--111",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Carrier detection for Sjögren-Larsson syndrome

AU - Kelson, T. L.

AU - Craft, D. A.

AU - Rizzo, W. B.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder associated with reduced activity of the fatty alcohol: NAD+ oxidoreductase complex (FAO). Recent studies indicate that SLS patients are specifically deficient in the fatty aldehyde dehydrogenase (FALDH) component of FAO. To investigate the possibility of carrier detection for SLS, FAO and FALDH activities were measured in cultured skin fibroblasts from normal controls, obligate SLS heterozygotes, and SLS homozygotes using the 18-carbon substrates octadecanol and octadecanal. Three of 11 heterozygotes for SLS had FAO activities that were within the normal range; the other 8 SLS heterozygotes had FAO activities below normal. In contrast, fibroblast FALDH activity was more effective than FAO in discriminating SLS heterozygotes from normal controls. FALDH activity (nmol min-1 (mg protein)-1) in normal controls was 8.54 ± 1.16 (mean ± SD; range 6.95-10.77;n=12) and in SLS heterozygotes was 5.12 ± 1.31 (range 3.28-6.96;n=11), or 60 ± 15% of mean normal activity. One SLS heterozygote had an FALDH activity within the lower range of normal; this heterozygote had an FAO activity below normal. None of the SLS heterozygotes had an FAO or FALDH activity that was in the range of that measured in SLS homozygotes. These results indicate that measurement of FAO and FALDH activities in cultured skin fibroblasts using 18-carbon substrates is useful for SLS carrier detection.

AB - Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder associated with reduced activity of the fatty alcohol: NAD+ oxidoreductase complex (FAO). Recent studies indicate that SLS patients are specifically deficient in the fatty aldehyde dehydrogenase (FALDH) component of FAO. To investigate the possibility of carrier detection for SLS, FAO and FALDH activities were measured in cultured skin fibroblasts from normal controls, obligate SLS heterozygotes, and SLS homozygotes using the 18-carbon substrates octadecanol and octadecanal. Three of 11 heterozygotes for SLS had FAO activities that were within the normal range; the other 8 SLS heterozygotes had FAO activities below normal. In contrast, fibroblast FALDH activity was more effective than FAO in discriminating SLS heterozygotes from normal controls. FALDH activity (nmol min-1 (mg protein)-1) in normal controls was 8.54 ± 1.16 (mean ± SD; range 6.95-10.77;n=12) and in SLS heterozygotes was 5.12 ± 1.31 (range 3.28-6.96;n=11), or 60 ± 15% of mean normal activity. One SLS heterozygote had an FALDH activity within the lower range of normal; this heterozygote had an FAO activity below normal. None of the SLS heterozygotes had an FAO or FALDH activity that was in the range of that measured in SLS homozygotes. These results indicate that measurement of FAO and FALDH activities in cultured skin fibroblasts using 18-carbon substrates is useful for SLS carrier detection.

UR - http://www.scopus.com/inward/record.url?scp=0026609829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026609829&partnerID=8YFLogxK

U2 - 10.1007/BF01800352

DO - 10.1007/BF01800352

M3 - Article

C2 - 1583866

AN - SCOPUS:0026609829

VL - 15

SP - 105

EP - 111

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 1

ER -